Lamotrigine and Viberzi drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lamotrigine (lamotrigine) and Viberzi (eluxadoline). Common drug interactions include hypoaesthesia among females and anxiety among males.
The phase IV clinical study analyzes what interactions people have when they take Lamotrigine and Viberzi. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.
What is Lamotrigine?
Lamotrigine has active ingredients of lamotrigine. It is often used in bipolar disorder. eHealthMe is studying from 76,639 Lamotrigine users. Check the latest studies of Lamotrigine.
What is Viberzi?
Viberzi has active ingredients of eluxadoline. eHealthMe is studying from 3,077 Viberzi users. Check the latest studies of Viberzi.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
18 people who take Lamotrigine and Viberzi together, and have interactions are studied.

What are the common drug interactions of Lamotrigine and Viberzi, by gender? *:
female:
- Hypoaesthesia (reduced sense of touch or sensation)
- Nausea (feeling of having an urge to vomit)
- Cystitis (inflammation of the wall of the bladder)
- Dehydration (dryness resulting from the removal of water)
- Diarrhoea
- Fall
- Fluid retention (an abnormal accumulation of fluid in the blood)
- Gait disturbance
- Haematoma (collection of blood outside the blood vessels)
- Headache (pain in head)
male:
- Anxiety
- Decreased interest
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Depression
- Emotional distress
- Fibromyalgia (a long-term condition which causes pain all over the body)
- Impaired work ability
- Ligament rupture (tear in ligament)
- Mania (a state of abnormally elevated or irritable mood)
- Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
What are the common drug interactions of Lamotrigine and Viberzi, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Anxiety
- Decreased interest
- Depression
- Emotional distress
- Fibromyalgia (a long-term condition which causes pain all over the body)
- Impaired work ability
- Ligament rupture (tear in ligament)
- Mania (a state of abnormally elevated or irritable mood)
- Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
- Pain
30-39:
n/a
40-49:
- Alopecia (absence of hair from areas of the body)
- Aphasia (damage to the parts of the brain that control language)
- Asthenia (weakness)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Hypoaesthesia (reduced sense of touch or sensation)
- Malaise (a feeling of general discomfort or uneasiness)
- Poor venous access
- Sinusitis (inflammation of sinus)
- Viral infection
- Fungal infection
50-59:
- Blood pressure increased
- Bone pain
- Cystitis (inflammation of the wall of the bladder)
- Dehydration (dryness resulting from the removal of water)
- Diarrhoea
- Fall
- Fatigue (feeling of tiredness)
- Feeding disorder (when children refuse to eat certain food groups)
- Fluid retention (an abnormal accumulation of fluid in the blood)
- Fungal infection
60+:
- Chronic kidney disease
- Gout (uric acid crystals building up in the body)
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal failure (kidney dysfunction)
- Renal impairment (severely reduced kidney function)
What are the existing conditions these people have? *
- Immunodeficiency Common Variable: 11 people, 61.11%
- Pain: 5 people, 27.78%
- Stress And Anxiety: 5 people, 27.78%
- Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 4 people, 22.22%
- Nausea (feeling of having an urge to vomit): 4 people, 22.22%
- Muscle Spasms (muscle contraction): 4 people, 22.22%
- Mood Swings (an extreme or rapid change in mood): 4 people, 22.22%
- Migraine (headache): 4 people, 22.22%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 16.67%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.11%
* Approximation only. Some reports may have incomplete information.
Do you take Lamotrigine and Viberzi?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Lamotrigine (76,639 reports)
- Viberzi (3,077 reports)
Browse all drug interactions of Lamotrigine and Viberzi:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lamotrigine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Viberzi:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lamotrigine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Viberzi and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Alonso-Navarro H, Montes JM, Plaza-Nieto JF, Jiménez-Jiménez FJ, "Cataplexy Possibly Associated With Lamotrigine", Journal of clinical psychopharmacology, 2016 Aug .
- Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .
- Alonso-Navarro H, Montes JM, Plaza-Nieto JF, Jiménez-Jiménez FJ, "Cataplexy Possibly Associated With Lamotrigine", Journal of clinical psychopharmacology, 2016 Aug .
- Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on lamotrigine and eluxadoline (the active ingredients of Lamotrigine and Viberzi, respectively), and Lamotrigine and Viberzi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ingrezza cause Parkinson'S Disease? - a second ago
- Could Sennosides cause Diverticulitis? - 2 seconds ago
- Drug interactions of Telmisartan and Propranolol Hydrochloride - 2 seconds ago
- Could Norvasc cause Seizure Like Phenomena? - 4 seconds ago
- Could Jakafi cause Oesophageal Haemorrhage? - 5 seconds ago
- Could Nuvigil cause Diabetes? - 8 seconds ago
- Could Nuvaring cause Thrombophlebitis? - 11 seconds ago
- Could Enzalutamide cause Migraine? - 12 seconds ago
- Could Tramadol cause Osteonecrosis Of Jaw? - 20 seconds ago
- Could Omnaris cause Rashes? - 24 seconds ago